LEP and cancer: 2 and Figure. 4); there were only 4 cancers with a discordant result so that the overall agreement was higher than 93%. The coexpression of leptin and ObR was confirmed both in HER2-positive and in HER2-negative subgroups; the overall agreement was 97% and 89% respectively (Table. 2).